These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 30713078)

  • 1. Clinical dashboard development and use for academic detailing in the U.S. Department of Veterans Affairs.
    Lau MK; Bounthavong M; Kay CL; Harvey MA; Christopher MLD
    J Am Pharm Assoc (2003); 2019; 59(2S):S96-S103.e3. PubMed ID: 30713078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Enhancing Quality of Prescribing Practices for Older Veterans Discharged From the Emergency Department (EQUIPPED) Potentially Inappropriate Medication Dashboard: A Suitable Alternative to the In-person Academic Detailing and Standardized Feedback Reports of Traditional EQUIPPED?
    Burningham Z; Jackson GL; Kelleher J; Stevens M; Morris I; Cohen J; Maloney G; Vaughan CP
    Clin Ther; 2020 Apr; 42(4):573-582. PubMed ID: 32222360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a pharmacy-led virtual academic detailing program at the US Veterans Health Administration.
    Himstreet JE; Shayegani R; Spoutz P; Hoffman JD; Midboe AM; Hillman A; Marin J; Chen A; Smith JP; Manning JM; Almeida A; Gray CP; Erhardt TA; Garcia CC; Freeman BA; Christopher MLD; Bounthavong M
    Am J Health Syst Pharm; 2022 May; 79(11):909-917. PubMed ID: 35084487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.
    Bounthavong M; Devine EB; Christopher MLD; Harvey MA; Veenstra DL; Basu A
    Health Serv Res; 2019 Oct; 54(5):1055-1064. PubMed ID: 31313839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Providers' Perception to Naloxone Education for Opioid Overdose After Receiving Academic Detailing at the U.S. Department of Veterans Affairs.
    Bounthavong M; Christopher MLD; Veenstra DL; Basu A; Devine EB
    J Pharm Pract; 2023 Jun; 36(3):514-522. PubMed ID: 34766510
    [No Abstract]   [Full Text] [Related]  

  • 6. Virtual academic detailing (e-Detailing): A vital tool during the COVID-19 pandemic.
    Hoffman JD; Shayegani R; Spoutz PM; Hillman AD; Smith JP; Wells DL; Popish SJ; Himstreet JE; Manning JM; Bounthavong M; Christopher MLD
    J Am Pharm Assoc (2003); 2020; 60(6):e95-e99. PubMed ID: 32747164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Implementing an Academic Detailing Program on Opioid-Benzodiazepine Co-Prescribing Trends at the U.S. Department of Veterans Affairs.
    Bounthavong M; Lau MK; Kay CL; Wells DL; Popish SJ; Harvey MA; Himstreet JE; Grana A; Freeman BA; Morillo CM; Christopher MLD
    Pain Med; 2021 Jun; 22(6):1426-1434. PubMed ID: 33749779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of virtual to in-person academic detailing on naloxone prescribing rates at three U.S. Veterans Health Administration regional networks.
    Bounthavong M; Shayegani R; Manning JM; Marin J; Spoutz P; Hoffman JD; Harvey MA; Himstreet JE; Kay CL; Freeman BA; Almeida A; Christopher MLD
    Int J Med Inform; 2022 May; 161():104712. PubMed ID: 35196600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultivating change door to door: Educational outreach to improve prescribing practices in rural veterans with posttraumatic stress disorder.
    Montaño M; Bernardy NC; Sherrieb K
    Subst Abus; 2017; 38(2):129-134. PubMed ID: 28277828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of academic detailing on benzodiazepine use among veterans with posttraumatic stress disorder.
    Bounthavong M; Lau MK; Popish SJ; Kay CL; Wells DL; Himstreet JE; Harvey MA; Christopher MLD
    Subst Abus; 2020; 41(1):101-109. PubMed ID: 30870137
    [No Abstract]   [Full Text] [Related]  

  • 11. VA residential substance use disorder treatment program providers' perceptions of facilitators and barriers to performance on pre-admission processes.
    Ellerbe LS; Manfredi L; Gupta S; Phelps TE; Bowe TR; Rubinsky AD; Burden JL; Harris AH
    Addict Sci Clin Pract; 2017 Apr; 12(1):10. PubMed ID: 28372579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in naloxone prescriptions prescribed after implementation of a National Academic Detailing Service in the Veterans Health Administration: A preliminary analysis.
    Bounthavong M; Harvey MA; Wells DL; Popish SJ; Himstreet J; Oliva EM; Kay CL; Lau MK; Randeria-Noor PP; Phillips AG; Christopher MLD
    J Am Pharm Assoc (2003); 2017; 57(2S):S68-S72. PubMed ID: 28089521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, implementation and user experience of the Veterans Health Administration (VHA) dialysis dashboard.
    Fischer MJ; Kourany WM; Sovern K; Forrester K; Griffin C; Lightner N; Loftus S; Murphy K; Roth G; Palevsky PM; Crowley ST
    BMC Nephrol; 2020 Apr; 21(1):136. PubMed ID: 32299383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a hospital-wide quality and safety dashboard: a qualitative research study.
    Weggelaar-Jansen AMJWM; Broekharst DSE; de Bruijne M
    BMJ Qual Saf; 2018 Dec; 27(12):1000-1007. PubMed ID: 29950323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain Care in the Department of Veterans Affairs: Understanding How a Cultural Shift in Pain Care Impacts Provider Decisions and Collaboration.
    Mattocks K; Rosen MI; Sellinger J; Ngo T; Brummett B; Higgins DM; Reznik TE; Holtzheimer P; Semiatin AM; Stapley T; Martino S
    Pain Med; 2020 May; 21(5):970-977. PubMed ID: 31886869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of naloxone prescribing patterns due to educational outreach conducted by full-time and part-time academic detailers at the U.S. Veterans Health Administration.
    Bounthavong M; Harvey MA; Kay CL; Lau MK; Wells DL; Himstreet JE; Popish SJ; Oliva EM; Christopher MLD
    J Am Pharm Assoc (2003); 2020; 60(4):639-646. PubMed ID: 31866383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014.
    Aspinall SL; Sales MM; Good CB; Calabrese V; Glassman PA; Burk M; Moore VR; Neuhauser MM; Golterman L; Ourth H; Valentino MA; Cunningham FE
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1058-63. PubMed ID: 27579828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid overdose education and naloxone distribution: Development of the Veterans Health Administration's national program.
    Oliva EM; Christopher MLD; Wells D; Bounthavong M; Harvey M; Himstreet J; Emmendorfer T; Valentino M; Franchi M; Goodman F; Trafton JA;
    J Am Pharm Assoc (2003); 2017; 57(2S):S168-S179.e4. PubMed ID: 28292502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of a transformational plan of care at a Veterans Affairs medical center.
    Elsasser EJ; White CA; Jones MR
    Am J Health Syst Pharm; 2018 Sep; 75(17 Supplement 3):S72-S76. PubMed ID: 30139726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmaceutical services in the Department of Veterans Affairs.
    Ogden JE; Muniz A; Patterson AA; Ramirez DJ; Kizer KW
    Am J Health Syst Pharm; 1997 Apr; 54(7):761-5. PubMed ID: 9099341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.